LPAR1 and acute respiratory distress syndrome: Similarly, the genetic deletion or pharmacologic antagonism of LPAR1 had no effect in vascular leak and edema upon LPS administration [35], the major hallmark of LPS/ALI-ARDS (and minimal, <25%, effects in inflammation, possibly due to genetic background differences of control mice).